News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
About the Author - Mark Terry

news@biospace.com

BioSpace News - By Mark Terry
Alexion (ALXN) Boss Shakes Up Executive Team, Head of R&D Retires, CFO and HR Exec Step Down 5/23/2017
Former Biogen (BIIB) Exec Launches Bain Capital’s First Life Sciences Fund With $750 Million 5/23/2017
Biogen (BIIB) Spinoff Bioverativ (BIVV) Takes Out Bay Area's True North in $825 Million Deal 5/23/2017
Actelion (ALIOF.PK) Provides An Update On The Progress Towards Launching Idorsia - Key Results For Pipeline Assets To Be Developed By Idorsia 5/22/2017
6 (Plus 2!) Most Notable ASCO Abstracts So Far 5/22/2017
Bill & Melinda Gates Foundation Bets on This Biotech to Win the Zika Race (Hint, It's a Unicorn) 5/22/2017
3 Biotechs Bouncing Back After a Tough 2016 5/22/2017
5 Biotechs Releasing Highly-Anticipated Data at ASCO 5/22/2017
Merck & Co. (MRK)'s Immuno-Oncology Star Racks Up Two New Bladder Cancer Approvals 5/19/2017
Former Xontogeny CEO Emerges to Helm Newly-Launched $25 Million Biotech Startup Accelerator 5/18/2017
GlycoMimetics (GLYC) Stock Takes Off on Positive Phase II Leukemia Data, Breakthrough Tag 5/18/2017
Confident Johnson & Johnson (JNJ) Flexes Its Muscles, Plans 10 Blockbuster Approvals by 2021 5/18/2017
FDA Slaps Clinical Hold on Concert Pharma (CNCE)'s Hair Loss Drug 5/18/2017
Vesalius Raises €65 Million While Novartis AG (NVS) Alum's VC Seeks €50 Million to Bet on Italian Scientists 5/18/2017
Why Pfizer (PFE) May Need Another Big M&A for Growth 5/17/2017
3 Rock-Bottom Biotechs That Big Market Players are Betting On 5/17/2017
New FDA Head's First Order of Business: Inspection Staff Reorg and Lower Drug Prices 5/17/2017
Biogen (BIIB)'s CSO Quietly Leaves, But Will Still Get R&D Funding From the Biotech Giant 5/16/2017
With Plans for U.S. and China Manufacturing Plants, Athenex Gears Up for $100 Million IPO 5/16/2017
GlaxoSmithKline (GSK) Apparently Prepping to Buy Out Novartis Consumer Health Joint Venture Stake for $10.3 Billion 5/16/2017
Seattle's Genoa Pharma Banks $62 Million and Names a New CEO and CSO 5/16/2017
New York's Akari Puts CEO on Administrative Leave 5/15/2017
AstraZeneca PLC (AZN) Stock Hits 2017 High as Lung Cancer Med Reduces Death Risk in Phase III Study 5/15/2017
4 Cheapest Drug Stocks in the World 5/15/2017
Biogen (BIIB) Exec Leaves to Put Together and Helm New Biotech Startup 5/15/2017
Size Matters: Why a Biotech's Size Can Affect Your Career 5/12/2017
Top GlaxoSmithKline (GSK) Investor Cashes Out, Citing a Weak Pipeline and Lack of Strategic Options 5/12/2017
Interview Insider: Tips on How to Get Hired at Johnson & Johnson (JNJ), Bristol-Myers Squibb (BMY), and Novartis AG (NVS) 5/12/2017
Top 5 Jobs for Introverted Life Scientists 5/12/2017
Pfizer (PFE) Makes a $545 Million Deal With Another Bay Area Biotech, Sangamo (SGMO) 5/12/2017
Genentech (RHHBY)'s Top Cancer Prospect Flunks Phase III Test 5/12/2017
Daiichi Sankyo Abandons 6 Clinical Programs in Q1 Update 5/12/2017
PAREXEL (PRXL) to Slash Up to 1,200 Jobs Worldwide 5/11/2017
Another Top Sanofi Genzyme (SNY) Exec Jumps Ship 5/11/2017
4 Biotechs That Could Release Stock-Shattering Data Soon 5/11/2017
INC Research (INCR) Gobbles Up inVentiv Health (VTIV) in $4.6 Billion Deal 5/11/2017
Daiichi Sankyo Adds The Source-To-Pay Catalyst From Zycus To Boost Its Procurement Performance 5/11/2017
Kite Pharma (KITE) Stock Plunges After Report of Patient Death in CAR-T Clinical Trial 5/10/2017
CRO Giant PAREXEL (PRXL) Explores $4 Billion Sale, Stock Jumps 5/10/2017
Pfizer (PFE) Sheds More After Unloading Medivation (MDVN)'s Mission Bay Space 5/10/2017
The Bay Area Biotech That Generates Billions in Cash Flow Every Year (So Far) 5/10/2017
Charles River  (CRL): Business Is Booming With 500 Positions Open 5/9/2017
This Bay Area Biotech Snags $293 Million Pain Drug Pact With Novartis AG (NVS) 5/9/2017
3 Cancer Biotechs to Watch at ASCO 5/9/2017
3 Biotechs Predicted to Grow 415% and More in 2018 5/9/2017
Fast-Growing Intarcia Awaits Crucial FDA Decision in New Boston HQ 5/8/2017
This New Threat Could Cause Gilead (GILD) to Hit Bottom 5/8/2017
Conspiracy Theory: Did Puma Biotech (PBYI) Exec Resign Because of Bad News Ahead? 5/8/2017
Don't Count Us Out: Pfizer (PFE) Hints at a Possible Bristol-Myers Squibb (BMY) Deal 5/5/2017
Is This Fake News? Neurotrope (NTRP) Alzheimer's Release Takes Weird Spin 5/5/2017
Gilead (GILD) Hints at 5-Point Comeback Strategy 5/5/2017
Booming Blueprint (BPMC) to Expand Into Former GlaxoSmithKline (GSK) Site 5/5/2017
This One Drugmaker Has Paid Dividends the Past 120+ Years 5/5/2017
Pfizer (PFE) Axes 3 Drugs From Pipeline in Q1 5/4/2017
This is What Shaved $3 Billion Off of GlaxoSmithKline (GSK)'s Market Cap Last Month 5/4/2017
This Booming Biotech Inks Huge Lease in the East Bay 5/3/2017
Lack of Cash Isn't a Concern for These 3 Clinical-Stage Biotechs 5/3/2017
3 Biotechs That Have Surged 150%+ During Trump's First 100 Days 5/3/2017
AstraZeneca PLC (AZN) Hits Milestone With Approval of Potential Bladder Cancer Blockbuster 5/3/2017
3 Safe and Solid Pharma Stocks for 2017 5/2/2017
Wowsers! FDA Approves BioMarin (BMRN)'s Brineura, the First Drug for Batten Disease 5/2/2017
GlaxoSmithKline (GSK) Injects $139 Million in Maryland Expansion 5/2/2017
Why M&A Hungry Sanofi (SNY) Could be Gearing Up to Buy Sarepta (SRPT) 5/2/2017
Takeda (TKPYY)'s $5 Billion Bet on Ariad (ARIA) Pays Off With Accelerated Approval of Lung Cancer Med 5/1/2017
This Is By Far the #1 Highest Paying Non-Executive Biotech Job in the U.S. 5/1/2017
Top 10 R&D Scientist Skills in Demand 5/1/2017
The Biotech Job Title You've Probably Never Heard Of 5/1/2017
M&A Speculation Begins as Sarepta (SRPT) CEO Puts in His Notice 4/28/2017
Genentech (RHHBY) Quietly Shelves Phase II Cancer Contender 4/28/2017
Mark Your Calendars: 4 Biotechs Facing FDA Decision Dates in May 4/28/2017
Analyzing Wild Optimism and Questionable Studies for Alzheimer’s Drug Development 4/28/2017
Another Biotech is Born as Bay Area's BridgeBio Pharma Launches Eidos Therapeutics With $27 Million 4/28/2017
The FDA Calls Pfizer (PFE)’s Next-Generation Lung Cancer Drug a Breakthrough 4/28/2017
And So It Begins: Covance (LH) Cuts 100+ Employees in Shut Down 4/27/2017
Some Predict Biogen (BIIB)’s Alzheimer’s Drug Will Fail 4/27/2017
Dropping Revenue: Expect More Cuts and Closures as LabCorp (LH) Aligns Covance (LH) Biz 4/26/2017
Why High-Flying M&A Target Tesaro (TSRO) Recently Lost More Than a Quarter of Its Value 4/26/2017
Why This SoCal Pharma Could Be Your Best Bet on Alzheimer's 4/26/2017
Why Trump's Executive Order Could Rekindle M&A Feelings for Allergan (AGN), Pfizer (PFE) 4/26/2017
Gilead (GILD)'s $600 Million NASH Deal Finally Bears Fruit 4/26/2017
Embattled Marathon Pharma May Shutter Operations by May 1 4/26/2017
Rumor Mill: Johnson & Johnson (JNJ), Novartis AG (NVS) and Takeda (TKPYY) are All Making Googly Eyes at This Brazilian Drugmaker 4/26/2017
Fasten Your Seatbelt: Biogen (BIIB) Preps for a Deal-Making Bonanza 4/26/2017
How This Iowa Biotech Could be a Perfect Match for M&A Hungry Gilead (GILD) 4/25/2017
Why 90% of This $26 Billion Biotech's Sales Could be At Risk Within the Next 2 Years 4/24/2017
2 Biotech Players to Keep Your Eye On 4/24/2017
Immune Pharma CEO Steps Down to Lead R&D in Restructuring, May Spin Off Oncology Unit 4/24/2017
Former Pfizer (PFE) Cancer Scientist Gets All 5 Papers Retracted 4/24/2017
No Doubt: This is the Top Gene-Sequencing Stock to Buy This Year 4/21/2017
Facebook Gives Rare Peek Into Secretive Brain-Powered Tech Unit 4/21/2017
3 Intriguing Small-Cap Biotechs to Put on Your Watchlist 4/21/2017
Bay Area Startup Atomwise Offers a Compelling Deal to Scientists Hunting for New Drugs 4/21/2017
Novartis AG (NVS) Remains Hush-Hush About CAR-T Trial But the FDA is Impressed and Thinks It's a Breakthrough 4/20/2017
A Revealing Conversation With Booming Bay Area Biotech Relypsa (RLYP)’s President Scott Garland 4/20/2017
Exec Reveals Sanofi (SNY) is Hunting for M&As to Boost Diabetes Biz 4/20/2017
FDA's Shorten Review Time is a Bad Sign for Puma Biotech (PBYI)'s Controversial Cancer Drug 4/20/2017
It's Officially the End of the Road for Massachusetts Biotech Nuclea Biotechnologies 4/20/2017
How Pfizer (PFE) Made Most of Its $52.8 Billion Last Year 4/20/2017
Why Former Medivation (MDVN) CEO and a Once-Failed Alzheimer's Drug Could be a Recipe for Disaster for Axovant (AXON) 4/20/2017
Ex-Dendreon (DNDN) CEO Returns to Biotech, Throws a Lifeline to Struggling Nivalis (NVLS) 4/19/2017
Tech Giant Apple (AAPL) Hires Secret Team of Biomedical Engineers for Treating Diabetes 4/19/2017
How Biogen (BIIB) Lost Its Chance to Be the Hunter and Became the Hunted in Just a Few Months 4/19/2017
Perrigo (PRGO) Shakes Up Exec Roster and Board, Hands Out a Fistful of Pink Slips 4/18/2017
New Biotech Incubator Emerges in Washington, Aims to Create Jobs and Hub Outside of Seattle 4/18/2017
FDA Just Rejected Eli Lilly (LLY), Incyte (INCY)'s Rheumatoid Arthritis Drug Baricitinib 4/18/2017
You'll Want to Own This Biotech Stock in the Next Market Crash 4/17/2017
From Biohacker to Organ Farmer, You Won’t Believe These Amazing 8 Biotech Jobs of the Future! 4/17/2017
Chiltern International Ltd. Explores Sale Valued at $1.3 Billion 4/17/2017
Top 10 Best Innovative Pharma Companies to Work For 4/14/2017
Proxy War Between Bay Area Innovia and Sarissa Heats Up, Could Mother of All Bombs Follow at Next Week’s Board Meeting? 4/14/2017
Bristol-Myers Squibb (BMY) Inks Two Separate Pacts With Biogen (BIIB) and Roche (RHHBY) For a Total of Up to $1.1B 4/14/2017
Nothing's Gonna Stop Neurocrine Biosciences (NBIX) Now: Shares Jumped on FDA Approval of the First and Only Drug to Treat Tardive Dyskinesia for Adults 4/13/2017
The Top 3 Best Computer Science Jobs in Biotechnology 4/13/2017
Why These 3 Drugmakers Could Buy Incyte (INCY) 4/13/2017
Massachusetts’ Lyndra Nabs $23 Million as It Plans to Start Clinical Trials This Year 4/13/2017
Why This Bay Area Biotech Stock Grew 415% in the Last Year 4/13/2017
Look Out, Another Biotech Joins San Diego With $40 Million and Will Take on NASH 4/13/2017
Why Roche (RHHBY) is a Hot Pick for Investors Right Now 4/13/2017
Strike It Rich With These 3 Biotech Stocks That Have Late-Stage Drugs 4/13/2017
Look Out Biotech! Google (GOOG)'s Parent Alphabet Sets Sights on Poaching Top Talent From Life Sciences and Healthcare 4/12/2017
Massachusetts Startup Frequency Therapeutics Nabs $32 Million 4/12/2017
What Happens if Gilead (GILD) Went Bigger Than Incyte (INCY) and Made a Play for This Pharma Giant 4/12/2017
4-Person Biotech Pens R&D Deal Worth $1 Billion With Drug Giant Novartis AG (NVS) 4/12/2017
And He's Back! Medivation (MDVN)'s David Hung to Helm Vivek Ramaswamy's Axovant (AXON) 4/11/2017
Biohaven Eyes $100 Million IPO to Bankroll Trials of Shelved AstraZeneca PLC (AZN), Bristol-Myers Squibb (BMY) Drugs 4/11/2017
Sanofi Genzyme (SNY) Exec Exits to Become CMO of Flexion (FLXN)—Sanofi (SNY)'s Rumored Buyout Target 4/10/2017
Gilead (GILD) Quietly Starts Recruiting Employees for China Expansion 4/10/2017
The Bay Area Pharma Stock Investors Could Buy and Hold for the Next 20 Years 4/10/2017
Why Ex-Ariad (ARIA) CEO Joining This Biotech's Board Could Mean a Buyout Deal Is Coming 4/7/2017
3 Successful Data Science Students Tell You What It Takes To Become a Data Scientist 4/7/2017
Pharma Giant Merck & Co. (MRK) Considering 600-Job IT Hub in Austin 4/7/2017
Novogen (NVGN) Terminates Preclinical Program, Will Cut an Undisclosed Number of Jobs 4/6/2017
Sanofi Genzyme (SNY) Head to Leave After 23 Years on the Job, Replacement Named 4/6/2017
Ex-Gilead (GILD) Director Founded and Will Helm Bay Area Cancer Startup Apostle 4/6/2017
Unfavorable Ruling Forces Acorda (ACOR) to Pink Slip 20% of Jobs 4/6/2017
Pharma Giant Takeda (TKPYY) Turns to Tiny Finch Therapeutics to Develop GI Therapies Based on Bacteria Found in Poop 4/5/2017
3 Hot to Scorchingly Promising Biotech Stocks 4/5/2017
Aralez Slashing 32% of U.S. Salesforce to Save Some Cash 4/5/2017
Struggling Aviragen (AVIR) Slashes 25% of Workforce, Considers Strategic Options 4/4/2017
4 Drug Stocks With Major FDA Decisions Coming This Month 4/4/2017
Sarepta (SRPT) CEO Gives CMO Role to Former Amgen (AMGN)-Regeneron (REGN) Alum 4/4/2017
Bristol-Myers Squibb (BMY) Who? Why Pfizer (PFE) Could be Making Googly Eyes at This Michigan Biotech Instead 4/4/2017
What a Day! Genentech (RHHBY) Lands FDA Approval for First Drug to Treat Severe Multiple Sclerosis 4/4/2017
Sucampo (SCMP) Pays $200 Million Upfront for Rare Disease Biotech Vtesse 4/3/2017
3 Biotechs Wall Street Predicts is Heading Toward Tremendous Growth 4/3/2017
3 Biotechs That Could be Taken Out This Quarter 4/3/2017
2 Biotechs That May Disappear by 2020 4/3/2017
Novartis AG (NVS)'s Talent Woes Continue as Seattle Genetics (SGEN) Poaches a Top CAR-T Exec 4/3/2017
Interview Insider: Tips on How to Get Hired From Merck & Co. (MRK), Eli Lilly (LLY) and Pfizer (PFE) 4/3/2017
Google (GOOG) Backs Another Biotech Startup: This One Wants to Develop a 'Biotech Superglue' to Create New Vaccines 4/3/2017
Former Pfizer (PFE) Neuroscientist to Helm New York Biotech Vencerx 4/3/2017
Mass Layoffs Hit Ariad (ARIA) Employees After Takeda (TKPYY)'s $5.2 Billion Buyout Deal 3/31/2017
Novartis AG (NVS) Ordered to Hand Over 80,000 Records of `Sham' Events for Doctors 3/31/2017
Top Pros and Cons of Contract Work in the Life Sciences Industry 3/31/2017
Tango Therapeutics Officially Debuts With $55 Million and a Crew of Superstar Scientific Advisers 3/31/2017
How to Find Hidden Lucrative Life Science Jobs in Government 3/31/2017
The 4 Most Cash-Rich Drugmakers Right Now 3/31/2017
Bay Area's Depomed (DEPO) Craters as New CEO, Directors are Named in Deal With Activist Investor 3/30/2017
Massachusetts' Agenus (AGEN) to Phase Out 20% of Jobs, Shutter Switzerland Facility in Restructuring 3/30/2017
Novartis AG (NVS) Jumps Into the Front of the CAR-T Line With Speedy Review of New Leukemia Drug 3/30/2017
Celgene (CELG) Stocks Up on More Juno (JUNO) Stock After Failed Flagship Drug Trial 3/30/2017
Vertex (VRTX) Consolidating R&D Ops in 3 Locations, Shutters Site in Canada 3/30/2017
Cambridge Biotech Solid Biosciences Rakes in $50 Million Series C to Move DMD Program Forward 3/30/2017
Tiny Massachusetts Phenom Corbus (CRBP) Plunges Despite Reporting Positive Phase II CF Data 3/30/2017
And It Begins...President Trump Looks to Cut $1.2 Billion of NIH R&D Spending This Year 3/30/2017
Trump's FDA Head Nominee to Recuse Himself From Decisions Involving 20+ Companies 3/29/2017
Biogen (BIIB) Loses Gene Therapy Pioneer to REGENXBIO 3/29/2017
While 3-Way Bids Go On, STADA Arzneimittel (STAGn.DE) CEO's Car is Bugged, Received Photos of Himself in Personal or Private Biz Situations 3/29/2017
Johnson & Johnson (JNJ)'s $100,000 Anti-Burnout Program for Top Execs 3/29/2017
Never Say Never: Why Taking Out Bristol-Myers Squibb (BMY) Could Boost Pfizer (PFE)'s Value by $5 Billion 3/29/2017
GE Healthcare to Invest $500 Million and Hire 5,000 Software Engineers 3/28/2017
NYC Data Science Academy Founder Boots Up New Data Scientists’ Careers 3/28/2017
Filings Reveal Concert Pharma (CNCE) Spurned $250 Million Buyout Offer From Vertex (VRTX) in November 2016 3/27/2017
How This New Jersey Biotech is Taking on Amgen (AMGN) 3/27/2017
This Colorado Pharma May Not Have Enough Cash to Last 2017 3/27/2017
Rumor Alert: Sanofi (SNY) Close to Scooping Up This Massachusetts Biotech in $1 Billion+ Deal 3/27/2017
3 Biotechs the Super-Rich Regret Buying in 2017 (So Far) 3/27/2017
Google (GOOG)'s Mysterious Biotech Calico Forms a Rare Deal With C4 Therapeutics 3/27/2017
Turns Out Editas Medicine (EDIT)'s R&D Deal With Allergan (AGN) Could be Worth $1 Billion 3/24/2017
Biogen (BIIB)'s Victory Over $4 Billion MS Patent Spat Makes Company an Even More Attractive M&A Target 3/24/2017
Teva (TEVA) Backpedals on 6,000 Job Cuts, Says Figure is Too High 3/24/2017
MEDA to Shut Down Facility But Employees Could Land a Gig at Neighboring Akorn Pharma 3/24/2017
5 Biotechs the Super-Rich Are Favoring in 2017 (So Far) 3/23/2017
Novartis AG (NVS)'s Phase III Drug for Heart Failure Bombs Trial 3/23/2017
How To Rework Your Resume To Make The Big Data Leap From Tech To Biotech 3/23/2017
4 Small-Cap Biotechs to Consider if Gilead (GILD) Isn’t Doing it For You 3/22/2017
Facebook Hiring Dozens for Secretive Division, Rumored to be Working on Brain-Scanning Technology and Other Med Device 3/22/2017
Ex-Novartis AG (NVS) Exec to Take the Reins at Bay Area's Forty Seven on May 1 3/22/2017
Former Celgene (CELG) Exec to Helm Cipher Pharma (DND.TO) 3/22/2017
Questions Arise Over This Bay Area Biotech CEO's Doctorate Degree and His Time at the University of Pennsylvania 3/21/2017
For Sale: Nektar Therapeutics (NKTR) Plans to License Hot New Opioid Drug 3/21/2017
Ex-GlaxoSmithKline (GSK) Scientists' Pulmocide Hauls in $30.4 Million 3/21/2017
Investors Squeal With Delight as Eli Lilly (LLY)'s Breast Cancer Combo Succeeds in Phase III, Faces Tough Competition from Pfizer (PFE) and Novartis AG (NVS) 3/21/2017
Biogen (BIIB) Faces Biggest One-Day Drop 3/20/2017
Disappointment Hits as Amgen (AMGN)'s Repatha Prevents Heart Attacks, But Not Deaths 3/20/2017
Fired U.S. Attorney Preet Bharara Was Investigating New HHS Chief Tom Price 3/20/2017
FDA Deals Another Blow to AstraZeneca PLC (AZN)'s Blood Drug 3/20/2017
This CRISPR Startup Co-Founded by a 30-Year-Old Just Nabbed $38 Million for Pig-to-Human Transplants 3/17/2017
Life Hack for Scientists: 9 Web-Savvy Tips to Get Your CV or Resume to the Top of an HR Search 3/17/2017
300 Employees Impacted as Teva (TEVA) to Shut Down or Sell Virginia Plant 3/16/2017



//-->